Reference
Pacak K, Eisenhofer G, Ahlman H, et al, 2007 Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3: 92–102.
Lam JB, Shub C, Sheps SG, 1985 Reversible dilatation of hypertrophied left ventricle in pheochromocytoma: serial two-dimensional echocardiographic observations. Am Heart J 109: 613–615.
Wiswell JG, Crago RM, 1969 Reversible cardiomyopathy with pheochromocytoma. Trans Am Clin Climatol Assoc 80: 185–195.
Gilsanz FJ, Luengo C, Conejero P, Peral P, Avello F, 1983 Cardiomyopathy and phaeochromocytoma. Anaesthesia 38: 888–891.
Park JH, Kim KS, Sul JY, et al, 2011 Prevalence and patterns of left ventricular dysfunction in patients with pheochromocytoma. J Cardiovasc Ultrasound 19: 76–82.
Hjalmarson A, Kallfelt B, Swedberg K, Waagstein F, Waldenstrom A. Possible adrenergic effects on heart protein metabolism. Acta Med Scand Suppl 672: 85–93.
Pacak K, 2007 Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 92: 4069–4079.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dijkhuizen, A., van Hulsteijn, L.T., Bonsing, B. et al. Hypertensive crisis during adrenalectomy in a patient with pheochromocytoma and a HOCM with SAM. Hormones 12, 472–474 (2013). https://doi.org/10.1007/BF03401315
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03401315